Concepedia

Cmax Normalization

Cmax Normalization is a pharmacokinetic data normalization method that adjusts concentration measurements by the peak plasma concentration (Cmax) to enable comparative analysis of drug exposure profiles across different doses or formulations.

15

Publications

540

Citations

120

Authors

63

Institutions

Publications per year

2017–2026

3

Parents

Publications

15

Dose‐linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats

Dong Won Jeong, Young Hoon Kim, Hui Hyun Kim et al. · Biopharmaceutics & Drug Disposition · 2006 · 172 citations

, , +13

Bioavailability of anthocyanidin-3-glycosides following consumption of elderberry extract and blackcurrant juice

I. Bitsch, M. Janßen, M. Netzel et al. · International Journal of Clinical Pharmacology and Therapeutics · 2004 · 64 citations

, , +13

Validation of Early Human Dose Prediction: A Key Metric for Compound Progression in Drug Discovery

Ken Page · Molecular Pharmaceutics · 2015 · 62 citations

, , +16

Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males

Sébastien Vergne, Catherine Bennetau‐Pelissero, Valérie Lamothe et al. · British Journal Of Nutrition · 2007 · 37 citations · Full text

, , +12

Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study

Jesús Cebrecos, James D. Carlson, Gregorio Encina et al. · Clinical Therapeutics · 2021 · 35 citations · Full text

, , +13

1–5 of 15

Authors

120

  1. MC
    M. C. García‐Carbonell

    Universitat de València, Spain

    1 publications · 19 citations

    1

    h-index

  2. TS
    Trivadi S. Ganesan

    Cancer Institute (WIA), India

    1 publications · 10 citations

    1

    h-index

  3. GS
    G. Straß

    Justus-Liebig-Universität Gießen, Germany

    1 publications · 64 citations

    1

    h-index

  4. MS
    Mariano Sust

    Esteve Química (Spain), Spain

    1 publications · 35 citations

    1

    h-index

  5. GE
    Gregorio Encina

    Esteve Química (Spain), Spain

    1 publications · 35 citations

    1

    h-index

1–5 of 120

Institutions

63

  1. Thomas Jefferson University

    Philadelphia, United States

    2 h-index

    2 publications

    46 citations

  2. SK Group (South Korea)

    Seoul, South Korea

    1 h-index

    3 publications

    516 citations

  3. Quest Diagnostics (United States)

    Madison, United States

    1 h-index

    1 publications

    21 citations

  4. United States Food and Drug Administration

    Silver Spring, United States

    1 h-index

    2 publications

    50 citations

  5. Karolinska University Hospital

    Stockholm, Sweden

    1 h-index

    1 publications

    16 citations

  6. Ottawa Hospital Research Institute

    Ottawa, Canada

    1 h-index

    3 publications

    30 citations

  7. University of British Columbia

    Vancouver, Canada

    1 h-index

    3 publications

    30 citations

  8. University of Illinois Chicago

    Chicago, United States

    1 h-index

    1 publications

    16 citations

1–8 of 63

Venues

  1. PubMed

    Repository · 2 publications · 44 citations

    2

    h-index

  2. Drug Metabolism and Disposition

    1 publications · 19 citations

    1

    h-index

  3. Molecular Pharmaceutics

    1 publications · 62 citations

    1

    h-index

  4. Biopharmaceutics & Drug Disposition

    1 publications · 172 citations

    1

    h-index

  5. British Journal of Cancer

    BJC · 1 publications · 10 citations

    1

    h-index

1–5